Arrayit Corporation Announces Nationwide Allergy Testing Sales and Distribution Network
June 18 2018 - 4:30AM
Sunnyvale, June 18, 2018 (GLOBE NEWSWIRE) -- Arrayit
Corporation Announces Nationwide Allergy Testing Sales and
Distribution Network
June 18, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC),
a life sciences and personalized medicine company, announces that
the company has engaged a nationwide network of professional sales
representatives (“sales reps”) to sell and distribute the company’s
allergy tests across the Continental United States, with focus
areas in the Pacific Northwest, West, Southwest, Rocky Mountain,
Midwest, Northeast and Southeast regions. The network
comprises 1,700 sales professionals including 500 sales reps with
specific training in finger stick sampling, blood card collection
and microarray technology. This extensive professional
network will be used to enroll hospitals, health maintenance
organizations (HMOs), doctor’s and dentist’s offices, health
clinics and retail stores into the allergy-testing program.
Arrayit allergy tests utilize non-invasive and convenient finger
stick sampling and blood card collection, in conjunction with
patented and proprietary protein microarray technology, to rapidly
and accurately measure immunoglobulin E (IgE) antibodies in the
human bloodstream produced by exposure to 120 common food and
environmental allergens. Personalized allergy testing assists
health care professionals to more easily identify, treat and
prevent allergy and asthma by combining molecular testing with a
patient’s medical history, symptomology and a physician’s
diagnosis. Arrayit allergy tests are manufactured and
processed in the company’s Clinical Laboratory Improvement
Amendments (CLIA) laboratory licensed by the State of California
and the Centers for Medicare and Medicaid Services (CMS), and
benchmarked by the leading laboratory proficiency testing
organization, the College of American Pathologists (CAP).
Arrayit CEO Rene Schena states, “We perceive significant
synergies between our highly automated allergy testing technology
and our newly-contracted network of medical sales professionals
working on our behalf to promote allergy testing nationally to
patients covered by private and public health insurance.
Arrayit finger stick allergy tests are particularly beneficial to
pediatric patients, special needs children, seniors, and
immunotherapy patients requiring testing at frequent
intervals.”
About Arrayit
Arrayit Corporation, headquartered in Sunnyvale, California, leads
and empowers the research, biotechnology, pharmaceutical, clinical
and healthcare sectors through the discovery, development and
manufacture of proprietary life science and personalized medicine
products and services to advance biomedical research and improve
wellness and human health. Please visit www.arrayit.com for more
information.
Safe Harbor Statement
We have identified forward-looking statements by using words such
as "expect", "believe", and "should". Although we believe our
expectations are reasonable, our operations involve a number of
risks and uncertainties that are beyond our control, and these
statements may turn out not to be true. Risk factors associated
with our business, including some of the facts set forth herein,
are detailed in the Company's public filings.
CONTACT
Public Relations
Arrayit Corporation
Tel: 408-744-1331
Email: arrayit@arrayit.com
Web: www.arrayit.com
Public Relations
Arrayit Corporation
Tel: 408-744-1331
Email: arrayit@arrayit.com
Web: www.arrayit.com
Arrayit (CE) (USOTC:ARYC)
Historical Stock Chart
From Oct 2024 to Nov 2024
Arrayit (CE) (USOTC:ARYC)
Historical Stock Chart
From Nov 2023 to Nov 2024
